The Connect® Myeloid Disease Registry is a study to learn more about how myeloid diseases are treated in real-life settings. **Myeloid diseases** are blood-related conditions, like Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS), and more. This registry collects information on treatments and their results to help doctors make better treatment decisions. It also looks at special markers in the body to see if they can predict how well treatments work.
Key Points:
- Participants will receive standard treatments and routine check-ups as usual. Their treatment details and progress will be recorded every three months.
- To join, patients must be able to provide consent and complete health questionnaires in English or Spanish.
- Some people cannot join, including those in other clinical trials or those with certain myeloid conditions.
This study helps build a knowledge base for doctors about what treatments work best, in both community and academic settings. If you are interested in participating and meet the criteria, consider discussing it with your doctor.
How understandable was the trial content above?
Hard to understand
Easy to understand